share_log

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

美國腫瘤學網絡宣佈出席和參與領先的社區腫瘤學會議
GlobeNewswire ·  03/28 20:00

AON will attend the 2024 Community Oncology Conference as an exhibitor, and its leaders will serve as panelists in various educational sessions.

怡安將作爲參展商參加2024年社區腫瘤學會議,其領導人將作爲小組成員參加各種教育會議。

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

美國腫瘤學網絡宣佈出席和參與領先的社區腫瘤學會議

From left to right: Stephen "Fred" Divers, MD, AON's chief medical officer; James Gilmore, PharmD, AON's chief pharmacy & clinical services officer; Mark Moch, AON's chief information officer; Martin Palmeri, MD, Messino Cancer Center's medical oncologist; Alti Rahman, MHA/MBA, CSSBB, AON's chief strategy & innovation officer; and Jan Smithson, Genesis Cancer and Blood Institute's regional physician liaison manager.
從左至右:怡安首席醫學官斯蒂芬· “弗雷德” · 迪弗斯醫學博士;怡安首席藥房和臨床服務官詹姆斯·吉爾摩;怡安首席信息官馬克·莫赫;梅西諾癌症中心腫瘤內科醫生馬丁·帕爾梅里;怡安首席戰略與創新官CSSBB MHA/MBA Alti Rahman;創世紀癌症首席戰略與創新官揚·史密森以及血液研究所的區域醫生聯絡經理。

FORT MYERS, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC) announced its attendance and panel participation at the annual Community Oncology Alliance (COA) conference from April 4 to April 5 in Orlando, Florida, to further its mission of closing the cancer care gap and ensuring the viability of community oncology.

佛羅里達州邁爾斯堡,2024年3月28日(GLOBE NEWSWIRE)——美國腫瘤網絡(AON)(納斯達克股票代碼:AONC)宣佈出席4月4日至4月5日在佛羅里達州奧蘭多舉行的年度社區腫瘤聯盟(COA)會議並進行小組討論,以進一步履行其縮小癌症護理差距和確保社區腫瘤學可行性的使命。

"At AON, we are passionate about supporting the medical practices that reside in our hometowns because of the immense benefits they bring patients," said Stephen "Fred" Divers, MD, AON's chief medical officer, medical oncologist at Genesis Cancer and Blood Institute and co-chair of the COA conference. "We are embracing the conference's theme of 'Stronger Together' and believe in the power of collaboration to improve clinical and patient outcomes, ensuring that there is a healthier future for cancer patients across the nation. I look forward to witnessing our leaders who will take the stage as panelists to share insights that we hope will resonate and guide our fellow colleagues in the industry."

怡安首席醫學官、創世紀癌血研究所腫瘤科醫生、COA會議聯席主席Stephen “Fred” Divers醫學博士說:“在怡安,我們熱衷於支持家鄉的醫療機構,因爲它們爲患者帶來了巨大的好處。”“我們擁護會議的主題,即'團結起來更強大 ',並相信合作能夠改善臨床和患者預後,確保全國癌症患者擁有更健康的未來。我期待見證我們的領導者以小組成員的身份登臺分享見解,我們希望這些見解能夠引起共鳴並指導我們的業內同事。”

AON leaders invited to speak at the conference include the following individuals:

受邀在會議上發言的怡安領導人包括以下個人:

  • Jim Chen, MD, an AON consultant and incoming physician, is a panelist in the session "Is AI Ready for Prime Time for Cancer Care."
  • Stephen "Fred" Divers, MD, is a panelist in the sessions "Welcome From the Co-Chairs," "Defining Value in Oncology: Executing VBC Accurately & Ethically to Account for All Stakeholders," "Reflections From the Co-Chairs" and "Meeting Observations From the Co-Chairs."
  • James Gilmore, PharmD, AON's chief pharmacy and clinical services officer, is a panelist in the session "Managing Formularies: Successfully Navigating Multiple Formularies to Balance Clinical & Financial Outcomes."
  • Mark Moch, AON's chief information officer, is a panelist in the session "Preparing for Precision Medicine 2.0 in Community Oncology."
  • Martin Palmeri, MD, MBA, medical oncologist at Messino Cancer Centers, is a panelist in the session "Hospitals: Friend or Foe? Examining Independent Practice-Hospital Relationships & Trends."
  • Alti Rahman, MHA/MBA, CSSBB, AON's chief strategy and innovation officer, is a panelist in the sessions "Welcome From the Co-Chairs," "Guardians of Confidentiality: Navigating Cybersecurity & Data Privacy in Oncology," "Is AI Ready for Prime Time for Cancer Care," "Reflections From the Co-Chairs" and "Meeting Observations From the Co-Chairs."
  • Jan Smithson, regional physician liaison manager for Genesis Cancer and Blood Institute, is a panelist in the session "Marketing Matters: Driving Provider Referrals in Competitive Marketplaces."
  • 怡安顧問、即將上任的醫生Jim Chen醫學博士是 “人工智能爲癌症護理的黃金時段做好準備了嗎” 的小組成員。
  • Stephen “Fred” Divers,醫學博士,是 “聯席主席的歡迎”、“定義腫瘤學的價值:以準確和合乎道德的方式執行VBC以考慮所有利益相關者”、“聯合主席的反思” 和 “聯合主席的會議觀察” 等會議的小組成員。
  • 怡安首席藥房和臨床服務官PharmD詹姆斯·吉爾摩是 “管理處方組:成功瀏覽多個處方以平衡臨床和財務成果” 會議的小組成員。
  • 怡安首席信息官馬克·莫赫是 “爲社區腫瘤學中的精準醫療2.0做準備” 會議的小組成員。
  • 梅西諾癌症中心腫瘤內科醫生、醫學博士、工商管理碩士馬丁·帕爾梅里是 “醫院:朋友還是敵人?” 會議的小組成員研究獨立診所與醫院的關係和趨勢。”
  • Alti Rahman,碩士/工商管理碩士,CSSBB,怡安首席戰略和創新官,是以下會議的小組成員:“聯席主席的歡迎”、“保密守護者:探索腫瘤學領域的網絡安全和數據隱私”、“人工智能是否爲癌症護理的黃金時段做好了準備”、“聯合主席的反思” 和 “會議聯合主席的觀察”。
  • 創世紀癌症與血液研究所區域醫生聯絡經理揚·史密森是 “營銷事務:在競爭激烈的市場中推動提供商轉診” 會議的小組成員。

AON is a fellow leader in the community oncology sector and dedicated to paving the way for independent practices to thrive independently with its support and resources, generating new revenue streams and growth in locations and patient services. Since its inception, AON has provided administrative support and access to critical offerings such as the in-house pharmacy and laboratory services to independent oncology medical practices.

怡安是社區腫瘤學領域的領導者,致力於通過其支持和資源爲獨立診所的獨立發展鋪平道路,創造新的收入來源,促進地點和患者服務的增長。自成立以來,怡安一直爲獨立腫瘤學醫療機構提供行政支持和關鍵服務,例如內部藥房和實驗室服務。

Through the partnership with AON, physicians have the resources needed to focus on providing the highest standard of care to every patient while continuing to deliver comprehensive cancer care, therapies and expanded patient services in their clinics, reducing the reliance on larger health systems and other third-party companies.

通過與怡安的合作,醫生擁有所需的資源,可以集中精力爲每位患者提供最高標準的護理,同時繼續在診所提供全面的癌症護理、療法和擴大患者服務,從而減少對大型醫療系統和其他第三方公司的依賴。

"AON and COA share similar missions, which creates a strong foundation for impact in the community oncology industry, and we are excited to be involved in the COA conference this year," said Rahman, AON's chief strategy and innovation officer who also serves as co-chair of the COA conference. "In any sector of healthcare, the sharing of information, knowledge and best practices is important to achieving the necessary advancements in medicine. The conference brings together today's healthcare and community oncology leaders for two days of education and networking. We understand the future of healthcare is a collective effort, and the conference provides a platform to foster unity and the exchange of information. At AON, we strive to be more than event attendees and seek to be catalysts for community oncology."

怡安首席戰略和創新官、同時擔任COA會議聯席主席的拉赫曼說:“怡安和COA有着相似的使命,這爲社區腫瘤行業的影響奠定了堅實的基礎,我們很高興能參與今年的COA會議。”“在任何醫療保健領域,信息、知識和最佳實踐的共享對於實現醫學的必要進步都很重要。該會議彙集了當今的醫療保健和社區腫瘤學領袖,進行了爲期兩天的教育和交流。我們知道醫療保健的未來是一項集體努力,該會議爲促進團結和信息交流提供了一個平台。在怡安,我們努力成爲不僅僅是活動的參與者,而是尋求成爲社區腫瘤學的催化劑。”

AON is an exhibitor at the conference and can be found at booth 305.

怡安是本次大會的參展商,可在305號展位找到。

For more information about AON, visit .

有關 AON 的更多信息,請訪問。

###

###

About American Oncology Network

關於美國腫瘤網絡

American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON's rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at .

美國腫瘤學網絡(AON)(納斯達克股票代碼:AONC)是一個由醫生和經驗豐富的醫療保健領導者組成的聯盟,旨在確保社區腫瘤學和其他專業的長期成功和可行性。怡安成立於2018年,其快速擴張的網絡代表着在20個州開展業務的220多家提供商。怡安通過其以醫生爲主導的模式開創了創新的醫療保健解決方案,促進了基於價值的護理,改善了患者的預後,同時降低了成本並擴大了獲得優質護理的機會。怡安爲其網絡醫生提供獨立成長所需的工具,同時提供全面的支持、收入多元化的綜合輔助服務和執業管理專業知識,使醫生能夠專注於最重要的事情——爲每位患者提供最高標準的護理。怡安致力於通過解決癌症治療中的差異並確保所有患者都能獲得實現最佳健康結果所需的護理來促進健康公平。怡安專注於創新與合作,正在塑造社區腫瘤學的未來。要了解更多信息,請訪問。

Attachment

附件

  • American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference
  • 美國腫瘤學網絡宣佈出席和參與領先的社區腫瘤學會議
CONTACT: Caroline Hewitt American Oncology Network 941.224.8736 Caroline.Hewitt@AONcology.com 
聯繫人:Caroline Hewitt 美國腫瘤學網絡 941.224.8736 Caroline.Hewitt@AONcology.com 

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論